These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 2044925)

  • 1. Use of azathioprine or 6-mercaptopurine in the treatment of Crohn's disease.
    O'Brien JJ; Bayless TM; Bayless JA
    Gastroenterology; 1991 Jul; 101(1):39-46. PubMed ID: 2044925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    Prefontaine E; Macdonald JK; Sutherland LR
    Cochrane Database Syst Rev; 2009 Oct; (4):CD000545. PubMed ID: 19821270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    Prefontaine E; Macdonald JK; Sutherland LR
    Cochrane Database Syst Rev; 2010 Jun; (6):CD000545. PubMed ID: 20556747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine.
    Bouhnik Y; Lémann M; Mary JY; Scemama G; Taï R; Matuchansky C; Modigliani R; Rambaud JC
    Lancet; 1996 Jan; 347(8996):215-9. PubMed ID: 8551879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis.
    Pearson DC; May GR; Fick GH; Sutherland LR
    Ann Intern Med; 1995 Jul; 123(2):132-42. PubMed ID: 7778826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease.
    Prefontaine E; Sutherland LR; Macdonald JK; Cepoiu M
    Cochrane Database Syst Rev; 2009 Jan; (1):CD000067. PubMed ID: 19160175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azathioprine or 6-mercaptopurine for inducing remission of Crohn's disease.
    Sandborn W; Sutherland L; Pearson D; May G; Modigliani R; Prantera C
    Cochrane Database Syst Rev; 2000; (2):CD000545. PubMed ID: 10796557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined use of cyclosporine and azathioprine or 6-mercaptopurine in pediatric inflammatory bowel disease.
    Ramakrishna J; Langhans N; Calenda K; Grand RJ; Verhave M
    J Pediatr Gastroenterol Nutr; 1996 Apr; 22(3):296-302. PubMed ID: 8708884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Optimization of immunomodulatory treatment with azathioprine or 6-mercaptopurine in inflammatory bowel disease].
    Bastida Paz G; Nos Mateu P; Aguas Peris M; Beltrán Niclós B; Rodríguez Soler M; Ponce García J
    Gastroenterol Hepatol; 2007 Nov; 30(9):511-6. PubMed ID: 17980127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of 6-mercaptopurine/azathioprine as the immunomodulator of choice for moderately active Crohn's disease: pro.
    Hyams JS
    Inflamm Bowel Dis; 2005 Feb; 11(2):197-9. PubMed ID: 15677914
    [No Abstract]   [Full Text] [Related]  

  • 12. The use of 6-mercaptopurine in patients with inflammatory bowel disease after failure of azathioprine therapy.
    Boulton-Jones JR; Pritchard K; Mahmoud AA
    Aliment Pharmacol Ther; 2000 Dec; 14(12):1561-5. PubMed ID: 11121903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive factors of response of perianal Crohn's disease to azathioprine or 6-mercaptopurine.
    Lecomte T; Contou JF; Beaugerie L; Carbonnel F; Cattan S; Gendre JP; Cosnes J
    Dis Colon Rectum; 2003 Nov; 46(11):1469-75. PubMed ID: 14605564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experiences with 6-mercaptopurine and azathioprine therapy in pediatric patients with severe ulcerative colitis.
    Kader HA; Mascarenhas MR; Piccoli DA; Stouffer NO; Baldassano RN
    J Pediatr Gastroenterol Nutr; 1999 Jan; 28(1):54-8. PubMed ID: 9890469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW; Tsoulis DJ; Macdonald JK; Feagan BG
    Cochrane Database Syst Rev; 2012 Dec; 12():CD003459. PubMed ID: 23235598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 6-mercaptopurine in patients with inflammatory bowel disease and previous digestive intolerance of azathioprine.
    Domènech E; Nos P; Papo M; López-San Román A; Garcia-Planella E; Gassull MA
    Scand J Gastroenterol; 2005 Jan; 40(1):52-5. PubMed ID: 15841714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy with oral tacrolimus (FK506) and azathioprine or 6-mercaptopurine for treatment-refractory Crohn's disease perianal fistulae.
    Lowry PW; Weaver AL; Tremaine WJ; Sandborn WJ
    Inflamm Bowel Dis; 1999 Nov; 5(4):239-45. PubMed ID: 10579116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term immunosuppressive treatment in Crohn's disease.
    Nyman M; Hansson I; Eriksson S
    Scand J Gastroenterol; 1985 Dec; 20(10):1197-203. PubMed ID: 3912958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of 6-mercaptopurine/azathioprine as the immunomodulator of choice for moderately active Crohn's disease: balance.
    Jacobstein DA; Baldassano RN
    Inflamm Bowel Dis; 2005 Feb; 11(2):203-5. PubMed ID: 15677916
    [No Abstract]   [Full Text] [Related]  

  • 20. Azathioprine and 6-mercaptopurine for the treatment of perianal Crohn's disease in children.
    Jeshion WC; Larsen KL; Jawad AF; Piccoli DA; Verma R; Maller ES; Baldassano RN
    J Clin Gastroenterol; 2000 Apr; 30(3):294-8. PubMed ID: 10777191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.